Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR-IOR-17012332
ChiCTR-IOR-17012332Not yet recruitingNot Applicable

血浆肾素活性指导降压药物选择的效果

自筹1 site in 1 country300 target enrollmentStarted: September 1, 2017Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
血压达标率
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

评价血浆肾素活性指导降压药物选择的治疗效果和预后

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • •1、难治性高血压；2、年龄 18~75 岁；3、签署同意书。

Exclusion Criteria

  • •1、严重肝、肾疾病（GFR＜30ml/1.73m2 和 ALT 正常值上限 2.5 倍者）；2、 孕妇、哺乳期妇女或有妊娠意向者；3、 肿瘤； 4、继发性高血压；5、不能坚持随访或依从性较差者。

Arms & Interventions

对照组

传统方法选药

研究组

新方法选药

Outcomes

Primary Outcomes

血压达标率

Secondary Outcomes

  • 主要不良事件

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Phase 4
常见降压药物对 ARR 结果的影响高血压
ChiCTR2200056129400
Unknown
Phase 1
降压通络方对早中期高血压肾损害患者肾功能影响的临床研究
ChiCTR-IIR-16009015首都卫生发展科研专项项目118
Unknown
Not Applicable
藏族低-中危高血压患者一线降压药物比较研究
ChiCTR-IPR-17012046四川省科技厅课题1,593
Unknown
Not Applicable
藏族低-中危高血压患者一线降压药物比较研究
ChiCTR-IOR-17014105四川省科技厅科技支撑项目531
Unknown
Not Applicable
补肾降压方治疗肾虚型原发性高血压患者随机双盲、安慰剂平行对照临床试验
ChiCTR1900028572国家自然科学基金委80